Selected representative matters handled by the principal of the firm:
Transactional:
- Exclusive license and supply agreement with pharmaceutical partner for national brand OTC pain reliever and fever reducer drug
- Exclusive license and supply agreement with pharmaceutical partner for national brand OTC pain reliever drug
- Exclusive license and supply agreement with pharmaceutical partner for Rx oncology drug
- Exclusive license and supply agreement with pharmaceutical partner for Rx BPH drugs
- Exclusive license and supply agreement with pharmaceutical partner for Rx pain therapy drug
- Exclusive license and supply agreement with pharmaceutical partner for branded Rx neurological drug
- Master services agreement with branded pharmaceutical company for range of development and manufacturing services
- License agreement with pharmaceutical company to resolve Hatch Waxman patent dispute over vitamin D analogue. Exclusive development and supply agreement for national brand chewable allergy medication
- Exclusive development and supply agreement for national brand soft gel allergy medication.
- Exclusive supply agreement for generic Rx prescription omega-3 product for managing triglycerides
- Supply agreement for branded Rx prescription eicosapentaenoic acid product for managing triglycerides
- Cross-licensing arrangement between Fortune 100 chemical companies to resolve dispute over modified polymer technology
- Herbicide tolerant technology in and out licenses with multiple universities and commercialization partners
- Numerous development, supply, commercialization, etc. agreements in the pharmaceuticals and nutritionals sector
- Acquisition of US automotive parts company by Chinese manufacturer
- Prepared template quality agreements and pharmacovigilance agreements
Intellectual Property:
- Managed Para. IV patent challenge for generic BPH drug in collaboration with partner
- Managed Para. IV patent challenge for oncology drug in collaboration with partner
- Managed Para. IV patent challenge for vitamin D analogue
- Managed Para. IV patent challenge for pain therapy drug in collaboration with partner
- Successfully defended opposition in European Patent Office to grant of key pharmaceutical platform technology patent
- Successfully opposed grant European Patent for fiber configuration
- Due diligence on pesticide and biotechnology portfolio for acquirer of agricultural products business
- Managed relationship with the Argentinian department of agriculture for licensed crop protection technology portfolio
- Managed litigation invalidating key competitor patent in stain blocking technology
- Negotiated intellectual property aspects of joint venture with Chinese joint venture partner building a polymer extrusion facility in China
- Advised on Hatch-Waxman Paragraph IV notice packages
- Advised startup pharma company regarding foundation IP agreement related to peptide therapeutics
- Trademark portfolio management
- Trademark searching and opinion
- Patentability searching and opinions
- Advised on fair use / copyright infringement for use of tunes with parody lyrics